Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent/unresectable rectal cancer in patients with previous pelvic irradiation: results of a phase II study-Reference-Cited by-同舟云学术

Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent/unresectable rectal cancer in patients with previous pelvic irradiation: results of a phase II study

Published:2014-12 Issue:1 Volume:9 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Cai Gang,Zhu Ji,Hu Weigang,Zhang Zhen

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-014-0278-3.pdf

Reference17 articles.

1. van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van de Velde CJ: Dutch Colorectal Cancer G: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011, 12: 575-582. 10.1016/S1470-2045(11)70097-3

2. How P, Shihab O, Tekkis P, Brown G, Quirke P, Heald R, Moran B: A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol 2011, 20: e149-155. 10.1016/j.suronc.2011.05.001

3. Bouchard P, Efron J: Management of recurrent rectal cancer. Ann Surg Oncol 2010, 17: 1343-1356. 10.1245/s10434-009-0861-2

4. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009, 373: 811-820. 10.1016/S0140-6736(09)60484-0

5. Garcia-Aguilar J, Cromwell JW, Marra C, Lee SH, Madoff RD, Rothenberger DA: Treatment of locally recurrent rectal cancer. Dis Colon Rectum 2001, 44: 1743-1748. 10.1007/BF02234449

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dutch national guidelines for locally recurrent rectal cancer;Cancer Treatment Reviews;2024-06

2. TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial;Frontiers in Oncology;2023-11-20

3. Modern Techniques in Re-Irradiation for Locally Recurrent Rectal Cancer: A Systematic Review;Cancers;2023-10-03

4. Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: A systematic review;Cancer Treatment Reviews;2022-09

5. Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial;Journal of Gastrointestinal Oncology;2022-06